Vaxil Bio
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4576 Yonge St, Toronto, Ontario, M2N 6N4...Website
www.vaxil-bio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Vaxil Bio
Vaxil Bio is an Israeli biotechnology company specializing in cancer immunotherapy, with a focus on creating innovative treatments that target high-profile cancer antigens. Their lead product, Immucin, has received Orphan Drug Status from the FDA and EMA after successful clinical trials involving multiple myeloma patients. The company is supported by a team of specialized immunology scientists and has a strong foundation of scientific intellectual property. Vaxil aims to provide universally applicable immunotherapy solutions that overcome cancer resistance and harness potent immune responses.Explore more
Vaxil Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vaxil Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Vaxil Bio recently announced quarterly report
Product Launch: Get notified when Vaxil Bio launches new products
Funding: Get notified immidiatlly once Vaxil Bio has new funding data
Click to see if Vaxil Bio had a recent Job posting/layoffs
Vaxil Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Vaxil Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Vaxil Bio is spiking on competitors!
Check if Vaxil Bio has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Vaxil Bio as Masked Content
Find more new buyers
Compare Similar Companies to Vaxil Bio
Compare insights from companies similar to Vaxil Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vaxil Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vaxil Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vaxil Bio.
Vaxil Bio Tech Stack
A closer look at the technologies used by Vaxil Bio
See more technologies
Vaxil Bio News & Media
Vaxil Announces Update on Non-Brokered Private Placement
Not for distribution by US newswire or in United StatesVaxil Announces Non-Brokered Private Placement
Not for distribution by US newswire or in United StatesVAXIL: SHARE CONSOLIDATION
Not for distribution by US newswire or in United StatesVaxil: Management and Operational Update
Not for distribution by US newswire or in United States
Read more news
Top Business Services Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Vaxil Bio
Sign Up For FreeTo access detailed company insights
Vaxil Bio is an Israeli biotechnology company specializing in cancer immunotherapy, with a focus on creating innovative treatments that target high-profile cancer antigens. Their lead product, Immucin, has received Orphan Drug Status from the FDA and EMA after successful clinical trials involving multiple myeloma patients. The company is supported... Read More
